Jefferson Scientists Uncover New Evidence To Help Explain Statins’ Effects In Alzheimer’s Disease

Scientists at Jefferson Medical College and the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia have taken another step in understanding the potential effects of anti-cholesterol drugs on Alzheimer’s disease. They have identified a biochemical pathway that affects the activity of statins, particularly their ability to break down an early form of the protein amyloid that clusters and forms sticky plaques in the Alzheimer’s brain.
http://www.sciencedaily.com/releases/2004/10/041027144323.htm